首页> 美国卫生研究院文献>Journal of Clinical Microbiology >Rapid PCR-Based Molecular Pathotyping of H5 and H7 Avian Influenza Viruses
【2h】

Rapid PCR-Based Molecular Pathotyping of H5 and H7 Avian Influenza Viruses

机译:基于快速PCR的H5和H7禽流感病毒分子病理分型

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

While the majority of avian influenza virus (AIV) subtypes are classified as low-pathogenicity avian influenza viruses (LPAIV), the H5 and H7 subtypes have the ability to mutate to highly pathogenic avian influenza viruses (HPAIV) in poultry and therefore are the etiological agents of notifiable AIV (NAIV). It is of great importance to distinguish HPAIV from LPAIV variants during H5/H7 outbreaks and surveillance. To this end, a novel and fast strategy for the molecular pathotyping of H5/H7 AIVs is presented. The differentiation of the characteristic hemagglutinin (HA) protein cleavage sites (CSs) of HPAIVs and LPAIVs is achieved by a novel PCR method where the samples are interrogated for all existing CSs with a 484-plex primer mixture directly targeting the CS region. CSs characteristic for HP or LP H5/H7 viruses are distinguished in a seminested duplex real-time PCR format using plexor fluorogenic primers. Eighty-six laboratory isolates and 60 characterized NAIV-positive clinical specimens from poultry infected with H5/H7 both experimentally and in the field were successfully pathotyped in the validation. The method has the potential to substitute CS sequencing in the HA gene for the determination of the molecular pathotype, thereby providing a rapid means to acquire additional information concerning NAIV outbreaks, which may be critical to their management. The new assay may be extended to the LP/HP differentiation of previously unknown H5/H7 isolates. It may be considered for integration into surveillance and control programs in both domestic and wild bird populations.
机译:尽管大多数禽流感病毒(AIV)亚型都被归类为低致病性禽流感病毒(LPAIV),但是H5和H7亚型具有在家禽中突变为高致病性禽流感病毒(HPAIV)的能力,因此是病原学可通知的AIV(NAIV)的代理商。在H5 / H7爆发和监视期间,将HPAIV与LPAIV变体区分开非常重要。为此,提出了一种新颖且快速的H5 / H7 AIV分子病理分型策略。 HPAIV和LPAIV的特征性血凝素(HA)蛋白质切割位点(CSs)的分化是通过一种新颖的PCR方法实现的,该方法使用直接靶向CS区域的484重引物混合物对样品中的所有现有CS进行询问。 HP或LP H5 / H7病毒的特征性CSs使用半荧光双链荧光引物以半巢式实时荧光定量PCR格式进行区分。在验证中成功对来自H5 / H7感染家禽的86份实验室分离株和60份特征化的NAIV阳性临床标本进行了成功分型。该方法具有取代HA基因中CS测序来确定分子病理型的潜力,从而为获取有关NAIV爆发的附加信息提供了快速的手段,这可能对它们的治疗至关重要。新的检测方法可以扩展到以前未知的H5 / H7分离株的LP / HP分化。可以考虑将其纳入家禽和野生鸟类种群的监视和控制程序中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号